BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 16687201)

  • 1. Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: a comparison among three different regimens.
    Casadei L; Zamaro V; Calcagni M; Ticconi C; Dorrucci M; Piccione E
    Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):155-61. PubMed ID: 16687201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
    Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
    Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
    Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
    Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination.
    Mitwally MF; Abdel-Razeq S; Casper RF
    Reprod Biol Endocrinol; 2004 Jul; 2():55. PubMed ID: 15239837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination.
    Papageorgiou TC; Guibert J; Savale M; Goffinet F; Fournier C; Merlet F; Janssens Y; Zorn JR
    BJOG; 2004 Nov; 111(11):1277-82. PubMed ID: 15521875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of simultaneous hCG administration with intrauterine insemination in stimulated cycles.
    Aydin Y; Hassa H; Oge T; Tokgoz VY
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):444-8. PubMed ID: 23932307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin.
    Vlahos NF; Coker L; Lawler C; Zhao Y; Bankowski B; Wallach EE
    Fertil Steril; 2005 May; 83(5):1510-6. PubMed ID: 15866592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
    Demirol A; Gurgan T
    Hum Reprod; 2007 Jan; 22(1):97-100. PubMed ID: 16954409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
    Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double vs. single intrauterine insemination per cycle: use in gonadotropin cycles and in diagnostic categories of ovulatory dysfunction and male factor infertility.
    Randall GW; Gantt PA
    J Reprod Med; 2008 Mar; 53(3):196-202. PubMed ID: 18441725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography.
    Farhi J; Ben-Haroush A; Lande Y; Fisch B
    Fertil Steril; 2007 Aug; 88(2):396-400. PubMed ID: 17445812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    Exp Clin Endocrinol Diabetes; 1998; 106(5):435-9. PubMed ID: 9831312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
    Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
    Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
    Kabli N; Sylvestre C; Tulandi T; Buckett W
    Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination. Influence of the number of mature follicles at hCG administration.
    Kaplan PF; Katz SL; Thompson AK; Freund RD
    J Reprod Med; 2002 Jul; 47(7):535-9. PubMed ID: 12170528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of factors influencing pregnancy rates in homologous intrauterine insemination.
    Ibérico G; Vioque J; Ariza N; Lozano JM; Roca M; Llácer J; Bernabeu R
    Fertil Steril; 2004 May; 81(5):1308-13. PubMed ID: 15136095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.